Relative Number and Distribution of Murine Hypothalamic Proopiomelanocortin Neurons Innervating Distinct Target Sites by King, Connie M. & Hentges, Shane T.
Relative Number and Distribution of Murine
Hypothalamic Proopiomelanocortin Neurons Innervating
Distinct Target Sites
Connie M. King, Shane T. Hentges*
Department of Biomedical Sciences, Colorado State University, Fort Collins, Colorado, United States of America
Abstract
Proopiomelanocortin (POMC) neurons send projections widely throughout the brain consistent with their role in regulating
numerous homeostatic processes and mediating analgesia and reward. Recent data suggest that POMC neurons located in
the rostral and caudal extents of the arcuate nucleus of the hypothalamus may mediate selective actions, however it is not
clear if POMC neurons in these regions of the arcuate nucleus innervate specific target sites. In the present study,
fluorescent microspheres and cholera toxin B were used to retrogradely label POMC neurons in POMC-DsRed transgenic
mice. The number and location of POMC cells projecting to the supraoptic nucleus, periaqueductal gray, ventral tegmental
area, paraventricular nucleus, lateral hypothalamic nucleus, amygdala and the dosal vagal complex was determined. Tracer
injected unilaterally labeled POMC neurons in both sides of the arcuate nucleus. While the total number of retrogradely
labeled cells in the arcuate nucleus varied by injection site, less than 10% of POMC neurons were labeled with tracer
injected into any target area. Limited target sites appear to be preferentially innervated by POMC neurons that reside in the
rostral or caudal extremes of the arcuate nucleus, whereas the majority of target sites are innervated by diffusely distributed
POMC neurons. The modest number of cells projecting to each target site indicates that relatively few POMC neurons may
mediate potent and specific physiologic responses and therefore disturbed signaling in a very few POMC neurons may have
significant consequences.
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Introduction
Hypothalamic POMC neurons have been the focus of much
investigation recently due to their ability to inhibit food intake and
reduce body weight [1]. POMC neurons primarily affect energy
balance through the release of the peptide alpha-melanocyte
stimulating hormone (a-MSH) although these neurons also release
other melanocortins and the opioid beta-endorphin (b-end) which
can also affect energy balance [1], reward and analgesia [2,3]. In
addition to the peptides cleaved from the POMC prohormone,
POMC neurons can also express several other peptide and non-
peptide transmitters including nociceptin [4] cocaine-amphet-
amine-regulated transcript [5], acetylcholine [6], GABA [7,8] and
glutamate [8,9] adding to the ability of these neurons to regulate a
wide range of physiologic processes.
Fibers and axon terminals immunoreactive for POMC peptides
have been detected throughout the brain and are particularly
dense in areas involved in general homeostasis such as hypotha-
lamic and brainstem nuclei, as well as areas that mediate reward
(e.g. ventral tegmental area, stria terminalis, nucleus accumbens
and lateral hypothalamus) [10,11,12,13]. POMC-containing fibers
are also present in the amygdala, periaqueductal grey and various
other structures [10,11,12,13]. Although there is a small group of
POMC neurons in the nucleus of the solitary tract (NTS) [14,15]
lesion and tract tracing studies indicate that hypothalamic POMC
neurons are a primary source of POMC-peptide immunoreactive
fibers [15,16,17]. The physiologic actions of NTS-derived POMC
peptides are not are not well defined primarily for technical
reasons, including a low number of POMC neurons in the region
(,200 POMC in the mouse NTS compared to .3,000 in the
arcuate nucleus) [18] and that POMC peptides are difficult to
detect in neuronal cell bodies in NTS using immunohistochemical
methods [18,19]. Although there are local brainstem projections
from POMC somas in the NTS [20], the majority of POMC
peptide immunoreativity in the hypothalamus, forebrain and even
the NTS arises from hypothalamic POMC neurons [15,20,21].
The actions of POMC peptides are dependent on the array of
receptors expressed at specific sites that the neurons innervate as
well as the connectivity and output of downstream target sites.
Therefore, blocking the actions of POMC-derived peptides at very
specific target sites can have distinct physiologic consequences. For
example, recent work demonstrates that a-MSH acts on its
receptors in the paraventricular nucleus (PVN) to inhibit food
intake [22], but acts on neurons outside of the PVN to affect
metabolism [23].
In addition to a single POMC peptide having diverse actions at
specific target sites, individual POMC neurons in the hypothal-
amus can vary in the compliment of transmitters that they express
[8,24] and subpopulations of POMC neurons respond differently
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signals including leptin and insulin [25,26]. Selective regulation
and heterogeneity in transmitter phenotype often correlate well
with the cell’s location within the rostral-caudal and/or medial-
lateral extent of the arcuate nucleus of the hypothalamus
[8,27,28]. Thus, the present experiments used retrograde tract
tracing to address the hypothesis that POMC neurons residing in
different areas of the arcuate nucleus innervate discrete target sites.
The results indicate that retrograde tracer injected into any of the
8 target sites tested labeled ,10% or less of POMC neurons.
Considerable variability in the rostral/caudal distribution of
POMC cells innervating select target sites was noted and the
dorsal vagal complex appears to receive projections from POMC
neurons in the rostral portion of the arcuate nucleus selectively.
Altogether the data provide a comprehensive analysis of
hypothalamic POMC neuron projections to a wide range of
target sites.
Methods
Animals
Male mice expressing the fluorescent protein discoma red
(DsRed) under the control of the Pomc promoter (POMC-DsRed)
were used for all experiments. All mice were 8 weeks old at the
time of tracer injection. The mice were produced by standard
techniques as described previously [8] and backcrossed onto the
C57BL/6J genetic background. The reliable expression of the
DsRed transgene in authentic POMC neurons was previously
demonstrated [8] and the transgene does not appear to affect the
health or basal electrical properties of POMC neurons according
to earlier studies [8,29]. Mice were housed at controlled
temperature (22–24uC) with a 12 h light/dark cycle and were
given standard rodent chow and tap water ad libitum. All animal
procedures met United States Public Health Service guidelines as
outlined in the Guide for the Care and Use of Laboratory Animals
of the National Institutes of Health and were approved by the
Institutional Animal Care and Use Committee at Colorado State
University (approval number 10-1915).
Stereotaxic microinjection
Fluorescent microspheres (0.04 mm, Invitrogen) or AlexaFluor-
647 conjugated-cholera toxin subunit B (CTB, Invitrogen) was
microinjected unilaterally (unless otherwise indicated) into target
sites of anesthetized (2–5% isofluorane) mice under aseptic
conditions using a small animal stereotax (Kopf Instruments).
Animal heath was monitored throughout all procedures and all
efforts were made to minimize distress. All injections were 200 nl
(except where noted) and were delivered via a 25 gauge (internal
diameter, 0.13 mm; outer diameter, 0.483 mm) Hamilton syringe
over 2 min. The needle was left in place for .3 min before being
withdrawn slowly over 2 min. The coordinates for injections were
calculated using The Mouse Brain in Sterotaxic Coordinates, second
edition by Paxinos and Franklin and adjusted as needed to the
final coordinates as follows (mm from bregma, lateral, dorsal/
ventral, respectively): supraoptic nucleus (20.42, 21.5, 5.4);
paraventricular nucleus (20.94, 20.5, 5.5); lateral hypothalamus
(20.42, 21.3, 5); ventral tegmental area (22.8, 20.24, 5.3);
periaqueductal grey (23.25, 20.04, 3.9); bed nucleus of the stria
terminals (1.25, 20.98, 4.1); amygdala (0, 22.75, 5); and dorsal
vagal complex (23, 20.4, 4.15). The success rate for hitting the
target site varied from ,43% (dorsal vagal complex) to .70%
(supraoptic nucleus and periaquedutal grey) depending on the size
of the target and proximity to a ventricle.
Tissue processing and imaging
5 d (unless otherwise noted) after injection, tissue was processed
for imaging using standard techniques. Briefly, Mice were deeply
anesthetized with sodium pentobarbital and perfused transcar-
dially first with a 10% sucrose solution, then with 4%
paraformaldehyde in 0.1 M potassium phosphate buffer. Brains
were post-fixed 18 h at 4uC in 4% paraformaldehyde and
sectioned at 50 mm on a vibratome. Sections were mounted in
the order sliced onto poly-lysine-coated slides and cover-slipped
with aqueous mounting media (Polysciences, Inc, Aqua/Poly
Mount). Imaging was performed on a Zeiss 510 Meta confocal
microscope. Green fluorescent microspheres were imaged using a
488/543 nm bandpass filter and emission was detected using a
505/530 nm bandpass filter, DsRed was imaged using a 488/
543 nm bandpass excitation filter and a 585/615 nm bandpass
emission filter and Alexa Fluor 647-conjugated CTB was detected
using a 514/633 nm bandpass excitation filter and a 650 nm
longpass emission filter. Images at each wavelength were collected
sequentially to limit the possibility of crossover between channels.
Three thin-plane images each 3 mm apart were merged into one
stacked image to be used for cell counts. Approximately one-tenth
of the total volume of the arcuate is included in the counting since
a ,10 mm stacked confocal image was produced for every-other
50 mm-thick section for counting. The exact z-position of the
images collected varied based on the location of cells in the slice,
but the most superficial ,10 mm from either surface was not
imaged to ensure collecting complete images and to avoid imaging
where there may be surface damage from cutting and handling of
the tissue. The location of each injection was verified in the fixed
tissue by visualizing the dye at the injection site.
Cell counting
For each brain sectioned, the hypothalamus was imaged such
that images were collected every 50–100 mm from the retro-
chiasmatic area (rca) through the caudal extent of the arcuate (arc)
nucleus. For data presentation and analysis, the area containing
POMC-DsRed neurons was divided into 3 regions identified as
rostral, mid and caudal arcuate nucleus with each division
representing ,450 mm of rostral/caudal length beginning at the
most rostral POMC-DsRed neuron observed. Three or 4 images
were collected through the rostral/caudal extent of each region.
POMC-DsRed and tracer-containing cells were counted from the
images displayed in Photoshop. Cells were marked during
counting to avoid duplicate counts and to allow switching between
channels to verify the presence or absence of co-labeling.
Statistics
Data are presented as mean 6 SEM. Statistical differences
between 2 groups were analyzed using two-sided unpaired t-tests.
Comparisons across different rostral-to-caudal divisions or among
target sites were made using one-way ANOVA with Bonferonni
post-hoc analyses. Data comparing tracer transport times were
analyzed using a Pearson test for correlation. Groups were
considered different if the p value was less than 0.05 with a 95%
confidence interval.
Results
Effects of injection volume, transport time, tracer and
accurate targeting on labeling
Experiments were performed to determine the appropriate
injection volume and transport time using injections into the VTA.
Increasing the injection volume into the VTA from 200 to 400 nl
did not affect the percent of POMC cells labeled (Figure 1A;
Projections from Hypothalamic POMC Neurons
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p=0.76) nor the total number of labeled cells in the arcuate
nucleus (difference of means 206, 95% confidence interval 251 to
463, p=0.1 by unpaired t-test). There was also no difference in the
percent of POMC neurons labeled with CTB when tissue was
processed 2, 5, 7, 14 or 18 days after the injection (Figure 1B;
p=0.9 by Pearson correlation, r=20.02, 95% confidence interval
20.47 to 0.43) suggesting that maximal labeling was achieved
within 2 days.
Since different tracers may be taken into axon terminals in
distinct ways with varying efficiency, an alternative retrograde
tracer was also tested for its ability to retrogradely label POMC
neurons. Fluorescent microspheres were injected into the VTA
(200 nl) 5 d prior to tissue processing. The percent of POMC
cells with fluorescent microspheres was not significantly different
from the percent labeled using CTB (6.260.82% versus
5.261.2% for CTB and microspheres, respectively; p=0.5,
N=5–6 by unpaired t-test). CTB was used for the majority of
studies as it more completely labeled entire cells compared to the
microspheres which resulted in diffuse punctate labeling (not
shown) and thus, CTB-positive cells were somewhat easier to
define.
CTB uptake into POMC neurons appears to be specific and
dependent on axon terminals. When CTB was injected into the
3rd ventrical, the cortex, various parts of the striatum including
nucleus accumbens, and very medial PVN, there were no POMC
cells labeled with tracer in the arcuate nucleus. Figure 1C shows
an example where the target was the rostral BST but the injection
was slightly rostral in the nucleus accumbens/caudate/putamen.
Although no cells in the arcuate nucleus were labeled with CTB,
there was labeling in the amygdalohippocampal area (AHiAL).
Often injections missing the target site were in areas with dense
POMC-DsRed-positive fibers and yet POMC cells in the arcuate
nucleus were not labeled with CTB. Therefore it seems unlikely
that fibers of passage are a significant source of labeling in the
arcuate nucleus.
Thus, based on the control experiments, all of the following
experiments were performed using 200 nl CTB tracer with 5 d
transport time with confidence that labeling was due to intact
projection fibers.
Figure 1. Effects of injection volume, transport time, and placement of injection. (A) Scatter plot indicating the percent of POMC-DsRed
neurons containing CTB after 200 nl or 400 nl injections of CTB into the VTA. Each point represents the counts from an individual animal. (B) Plot
indicating the percent of POMC-DsRed cells that contain CTB at various time-points after CTB was injected into the VTA. Each point represents the
counts from an individual animal. (C) Images show POMC-DsRed cells (red) and CTB-positive cells (green) in the AHiAL (left) and the arcuate nucleus
(right) after CTB was injected into the ventral striatum. There are no POMC-DsRed cells in the AHiAL and no CTB-positive cells in the arcuate nucleus.
The diagram shown for reference was adapted from Paxinos and Franklin (2nd edition,  2001). Abbreviations: BSTIA, bed nucleus of the stria
terminalis- intraamygdaloid subdivision; AHiAL, amygdalohippocampal area- anterolateral; PMco, posteromedial cortical amygdaloid nucleus; DG,
dentate gyrus; STh, subthalamic nucleus; LH, lateral hypothalamus; f, fornix; Arc, arcuate nucleus (MP, medial posterior; LP, lateroposterior); DM,
dorsomedial hypothalamic nucleus; 3V, third ventricle; ME, median eminence.
doi:10.1371/journal.pone.0025864.g001
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Retrograde tracer was injected into distinct brain regions
innervated by hypothalamic neurons. The location of each
injection was verified in fixed sections using low-power bright-
field microscopy to visualize the tissue combined with epifluores-
cence to detect the injection site (some example images are shown
in Figure 2). Any animals where the injection site could not be
positively confirmed were omitted from further analysis unless
Figure 2. Placement of CTB injections. Bright-field and epifluorescent images were taken in the identical field and overlayed to produce the
representative images in A–D (right side). The reference diagrams on the left side were adapted from the Mouse Brain Atlas of Paxinos and Franklin
(2nd edition,  2001). Coronal sections are shown for injections into (A) the supraoptic nucleus (SON), (B) the paraventricular nucleus (PVN) and (C)
the lateral hypothalamic area (LH). An injection into the ventral tegmental area (VTA) is shown in a slice prepared in the sagittal plane (D).
Abbreviations: f, fornix; 3V, third ventricle; LH, lateral hypothalamus; SO, supraoptic nucleus; opt, optic tract; sox, supraoptic decussation, PaLM,
paraventricular hypothalamic nucleus-lateral magnocellular; PaMM, paraventricular hypothalamic nucleus-medial magnocellular; PaDC, paraven-
tricular hypothalamic nucleus-dorsal cap; PaMP, paraventricular hypothalamic nucleus-medial parvicellular part; mt, mammillothalamic tract; ml,
medial lemniscus; VTA, ventral tegmental area; IPF, interpeduncular fossa.
doi:10.1371/journal.pone.0025864.g002
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injection site to cell bodies in distinct regions throughout the brain
in a manner that varied by the site injected. For example, CTB
injected into the ventral tegmental area (VTA) labeled cells in the
arcuate nucleus and also heavily labeled cells in the posterior
hypothalamus, ventral medial nucleus of the hypothalamus and
the preoptic area (Figure 3).
The number of labeled cells in the arcuate nucleus was
determined for each injection site. Injections into the supraoptic
nucleus (SON) resulted in the greatest total labeling in the arcuate
nucleus (ARC). Injections into the paraventricular nucleus (PVN),
lateral hypothalamus (LH), VTA, and periaqueductal grey (PAG)
also labeled many cells (Figure 4C). A modest number of cells were
labeled from the bed nucleus of the stria terminalis (BST) and
amygdala. Injections of tracer into the dorsal motor nucleus of the
vagus (10N) or more broadly- the dorsal vagal complex (DVC),
labeled very few neurons in the arcuate nucleus (Figure 4). Overall,
there was significant variability in the number of cells labeled
when CTB was injected into the 8 different sites (p=0.02 by 1-way
ANOVA). Labeling was evident both ipsilateral and contralateral
to the injection (Figure 4A & C). Although fewer cells were labled
contralateral to the injection, only the VTA and amygdala had
significantly less labeling on the contralateral side (p=0.02 and
p=0.05 for VTA and amygdala, respectively using unpaired t-
tests).
Number of POMC neurons with retrograde label
POMC neurons represent only a small subset of neurons in the
arcuate nucleus. Therefore, although a significant number of cells
in the arcuate nucleus were labeled with CTB, only a small
number of those were POMC neurons (Figure 4, inset red bars).
Between 1.7 and 7.9% of CTB-positive cells expressed POMC-
DsRed for all injection sites except DVC where 46% of the CTB-
containing cells were POMC neurons. The percentage of POMC
cells containing CTB varied significantly by injection site (p,0.01
by one-way ANOVA) in both the ipsilateral and contralateral sides
of the arcuate nucleus (Figure 5). There was not a statistically
significant difference in the percent of POMC cells labeled on the
ipsilateral or contralateral side of the arcuate nucleus for any
injection site (SON, difference of means 3.662.2% (95%
confidence interval 21.1 to 8.3), p=0.12; PVN, difference of
means 061.4% (95% confidence interval 23.0 to 3.0), p=1; LH,
difference of means 2.162.6% (95% confidence interval 23.4 to
8.1), p- 0.45; VTA, difference of means 1.161.3% (95%
confidence interval 21.8 to 3.9), p=0.43; PAG, difference of
means 0.3661.1% (95% confidence interval 22.0 to 2.7),
p=0.74; BST, difference of means 1.461.2% (95% confidence
interval 21.9 to 4.7), p=0.3; amygdala, difference of means
0.5360.44% (95% confidence interval 21.9 to 3.0), p=0.58; and
DVC, difference of means 0.0561.7% (95% confidence interval
24.8 to 4.9), p=0.98).
Location of POMC neurons labeled with CTB
To determine if POMC cells located along the rostral-to-caudal
extent of the arcuate nucleus may differentially project to certain
target sites, brain sections from rostral, mid and caudal regions of
the arcuate nucleus (as depicted in Figure 6A) were analyzed
separately. CTB injected into the PAG and DVC preferentially
labeled a higher portion of POMC neurons in the rostral-most
region of the arcuate nucleus (statistically significant only for the
DVC, p=0.003 by one-way ANOVA). Tracer injected into the
LH, VTA or amygdala labeled cells evenly throughout the arcuate
nucleus. When CTB was injected into the SON, PVN and BST,
fewer POMC cells labeled with CTB in the rostral portion of the
Figure 3. CTB selectively labels cell in distinct brain regions. (A)
A portion of the atlas page (Lateral 0.24) from Paxinos and Franklin (2nd
edition,  2001) corresponding to the sagittal section shown in (B) and
(C). The dotted line in (A) depicts where the images in (B) and (C) are
cropped. CTB was injected into the VTA and a low-power image
containing the arcuate nucleus was taken to reveal the distribution of
CTB (B). Fluorescence from the injection site can be seen at the upper
right edge of the photo in (B, marked with asterisk). (C) The same field
of view as in (B) imaged to reveal the POMC-Ds-Red labeled cells in the
arcuate and some of their prominent fibers rostral and caudal to the
arcuate nucleus. Abbreviations: ac, anterior commissure; PaAP, para-
ventricular hypothalamic nucleus-anterior parvocellular; PaLM, para-
ventricular hypothalamic nucleus-lateral magnocellular; PaMM, para-
ventricular hypothalamic nucleus-medial magnocellular; PaDC,
paraventricular hypothalamic nucleus-dorsal cap; PaPo, paraventricular
hypothalamic nucleus-posterior; PH, posterior hypothalamic area; MPA,
medial preoptic area; AHA, anterior hypothalamic area; LA, lateroanter-
ior hypothalamic nucleus; VMH, ventromedial hypothalamic nucleus;
DM, dorsomedial hypothalamic nucleus; Arc, arcuate hypothalamic
nucleus, MM, medial mammilary nucleus; IPF, interpeduncular fossa; OX,
optic chiasm; VTA, ventral tegmental area.
doi:10.1371/journal.pone.0025864.g003
Projections from Hypothalamic POMC Neurons
PLoS ONE | www.plosone.org 5 October 2011 | Volume 6 | Issue 10 | e25864arcuate nucleus as compared to the mid and caudal regions
(Figure 6B) although there were no statistically significant
differences in CTB labeling alone throughout the arcuate nucleus
for any injection site except for the DVC (p=0.009 by one-way
ANOVA and see table 1) where there is more CTB labeling
overall in the rostral portion of the arcuate nucleus (46% of which
is in POMC neurons). Differences between medial and lateral
portions of the arcuate nucleus were not apparent.
Discussion
The number and range of functions attributed to POMC
neurons and their transmitters underscores the importance of
better understanding the circuitry associated with these neurons.
Although many studies have examined output from the arcuate
nucleus [10,30], few have described outputs specifically from
POMC neurons [31]. Additionally, it is difficult to relate
information between different tracing studies due to differing
methods, tracers, and ways of reporting the results. By using
consistent methods and analyses for several target areas in the
same study, the present results represent a comprehensive analysis
of relative innervation to differing target sites and the location of
POMC cells that project to specific target sites. The results
indicate that only a small fraction (,10% or less) of POMC
neurons projects to any one target area although there are some
distinctions in whether POMC neurons in the rostral or caudal
portions of the arcuate nucleus are more likely to project to specific
target areas.
Hypothalamic targets of POMC neurons
POMC neurons innervate many regions of the hypothalamus
including the PVN [32], LH [33] and SON [34]. The results here
Figure 4. CTB labels many non-POMC cells and few POMC cells.
(A & B) Example images after CTB injection into the SON. (A) Low-power
image in the arcuate nucleus shows POMC neurons (red) and CTB-
containing neurons (green). The side of the arcuate corresponding to
the side of injection (ipsilateral) has more intense CTB labeling
compared to the contralateral side. (B) Higher magnification image
taken in the ipsilateral side shows POMC neurons with (white arrows)
and without CTB label. Many neurons contain CTB, but not POMC-
DsRed. 3V=3rd ventricle. (C) Graph showing the number of cells
imaged that have CTB after injections into the various target sites
(white bars). The number of CTB-positive cells that also express POMC-
DsRed are shown in the red portion of the bars. Solid bars correspond
to counts from the side of the arcuate nucleus ipsilateral to the
injection; striped bars correspond to the contralateral side. Data are
presented as mean 6 SEM. The numbers in parentheses indicate the
number of animals in each group. The asterisks denote p,0.05
compared to ipsilateral side for same injection target. Abbreviations:
SON, supraoptic nucleus; PVN, paraventricular nucleus; LH, lateral
hypothalamic area; VTA, ventral tegmental area; PAG, periaqueductal
gray; BST, bed nucleus of the stria terminalis; Amyg, amygdala; DVC,
dorsal vagal complex.
doi:10.1371/journal.pone.0025864.g004
Figure 5. The percent of POMC neurons retrogradely-labeled
with CTB varies by injection site. (A) Example images showing
POMC-DsRed cells (red) and CTB-containing cells (green) in the arcuate
nucleus after CTB was injected into the PVN. The percent of POMC-
DsRed cells that contain CTB is similar on the side of the arcuate nucleus
corresponding to the side receiving the injection (left picture) and the
side opposite the injection (right picture). Arrows indicate POMC-DsRed
cells that contain CTB. (B) Bar graph representing the percent of POMC-
DsRed cells labeled with CTB in the arcuate nucleus after CTB was
injected into the indicated target sites. There was a significant
difference in labeling across target sites (p,0.001); no statistical
differences were detected between the ipsilateral and contralateral
sides for any injection site. Numbers in parentheses indicate the
number of animals in each group. All data are mean 6 SEM.
doi:10.1371/journal.pone.0025864.g005
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however they also indicate that only a modest percent of POMC
neurons project to each of these hypothalamic areas (Figure 5).
Functional studies provide strong evidence that POMC peptides,
particularly a-MSH, activate a significant population of neurons in
the PVN to increase autonomic output [33,35] and inhibit food
intake [36]. While the present data indicate that only a fraction of
POMC neurons terminate in the PVN, it may be that this
relatively sparse innervation is sufficient to affect a large
population of cells. For example, in a previous study a-MSH
terminals were found on only 30% of thyrotropin-releasing-
hormone (TRH) neurons in the medial parvocellular PVN, yet all
TRH neurons in the region showed increased TRH mRNA with
a-MSH treatment [37]. Thus, a-MSH appears capable of
mediating a potent physiological response in more cells than are
directly innervated by POMC terminals.
Both b-end and a-MSH affect the activity of neurons in the
SON, particularly oxytocin-releasing neurons [38,39]. The present
results are in line with previous work demonstrating retrograde
labeling from the SON to the arcuate nucleus and in a subset
(,20%) of POMC neurons [34]. Similarly, POMC neurons
innervate selective neurons in the LH including those that express
orexin or melanin-concentrating hormone [33,40,41]. While it is
difficult to compare the results from previous studies with those
here quantatively due to the variety of tracers and animal species
used, it is clear that only a subset of POMC neurons innervates
each of the hypothalamic target sites.
Extrahypothalamic targets of POMC neurons
POMC neuron projections to the VTA, PAG, BST, and
amygdala have been demonstrated in immunohistochemical
studies and by measuring POMC peptides in these target regions
[31]. The retrograde labeling approach used here supports the
presence of POMC terminals in these extrahypothalamic regions.
Interestingly, despite little evidence of POMC-peptide containing
fibers in the VTA, injections of CTB into the VTA labeled
approximately the same percentage of POMC cells as when the
tracer was injected into hypothalamic nuclei (Figure 4). The
Figure 6. Rostral-to-caudal distribution of POMC neurons that project to distinct target sites. (A) Atlas diagrams modified from Paxinos
and Franklin (2nd edition,  2001) depicting the cut-offs used to define rostral, mid and caudal regions of the arcuate nucleus. Values are distance
from Bregma. (B) Bar graph showing the percent of POMC-DsRed cells that contained CTB in the rostral, mid and caudal portions of the arcuate
nucleus after CTB was injected into various target sites. Numbers in parentheses indicate the number of animals in each group. Asterisks indicate
p,0.05 compared to rostral sections for that injection site. All data are mean 6 SEM. Abbreviations: VMH, ventromedial hypothalamic nucleus; 3V,
third ventricle; Arc, arcuate nucleus (MP, medial posterior; LP, lateroposterior); sox, supraoptic decussation; opt, optic tract; LH, lateral hypothalamus.
doi:10.1371/journal.pone.0025864.g006
Table 1. Percent of POMC cells with CTB compared across rostral to caudal regions.
Areas Compared SON PVN LH VTA PAG BST Amyg DVC
Rost v. Mid 22.9
(210.4 to 4.6)
24.4
(210.0 to 1.2)
20.4
(29.7 to 8.9)
0.5
(26.8 to 7.7)
3.9
(21.0 to 8.8)
21.5
(28.1 to 5.1)
20.02
(22.7 to 2.7)
9.8 *
(3.6 to 16)
Rost v. Caud 22.8
(210.4 to 4.7)
24.3
(210.1 to 1.5)
20.4
(29.6 to 8.9)
20.9
(28.1 to 6.4)
2.9
(22.3 to 8.0)
21.5
(28.1 to 5.1)
1.1
(21.9 to 4.1)
9.6 *
(3.4 to 15.8)
Mid v. Caud 0.9
(27.4 to 7.6)
0.07
(25.7 to 5.9)
0.05
(29.2 to 9.3)
21.3
(28.6 to 6.0)
21.1
(26.2 to 4.0)
20.2
(26.6 to 6.6)
1.2
(21.9 to 4.2)
20.2
(26.4 to 6.0)
Mean difference for the percent of POMC cells that contain the retrograde tracer (CTB) between rostral (Rost), middle (Mid) and caudal (Caud) regions of the arcuate
nucleus with 95% confidence intervals in parentheses for tracer injections into each of the indicated target sites. Asterisks denote P,0.01.
doi:10.1371/journal.pone.0025864.t001
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previously indicated by the ability of melanocortin receptor
antagonists injected into the VTA to decrease behavioral responses
[42] and dopamine release [43]. Thus, the ,8% of POMC cells
that project to the VTA under basal conditions must release a
sufficient amount of transmitter to evoke physiologic responses.
Although tracer injections into the PAG or BST labeled
approximately the same number of total cells in the arcuate
nucleus as injections into the VTA and hypothalamic nuclei
(Figure 4), relatively fewer of the labeled cells were POMC
neurons (Figure 5) suggesting that these regions receive innerva-
tion from a very small number of POMC neurons. Despite the
small number of POMC neurons that appear to project to areas
like the PAG and BST, significant b-end and a-MSH release has
been noted in these regions [11,13,44], and POMC peptides
acting at receptors in the PAG and BST are suggested to play
important roles in analgesia and hypothalamus-pituitary-adrenal
axis activation, respectively [45,46,47]. Therefore, it is feasible that
the innervation from relatively few POMC neurons is sufficient to
mediate physiologic responses of POMC peptides in these areas.
POMC projections to the amygdala were previously indicated
by the presence of b-endorphin immunoreactive fibers [11] and
release of POMC peptides [13,48,49] into the amygdala. The
present results indicate only ,2% or less of POMC neurons in the
arcuate nucleus project to the amygdala (Figure 4) under basal
conditions. The low number of POMC neurons projecting to the
amygdala is somewhat surprising given the important role of
POMC peptides in this area to mediate aspects of appetite and
affective state [50,51,52]. However, it is possible that POMC
neurons innervate a part of the amygdala that was not targeted in
the current study.
Melanocortin receptors (MC4) are heavily expressed in the
dorsal vagal complex (DVC, 10N and NTS) [53,54]. The release
of POMC peptides into the hindbrain affects food intake and body
weight [55] and induces hypotension and bradycardia [56].
Stimulation studies [56] and recent retrograde labeling studies
[21] clearly indicate that arcuate nucleus POMC neurons mediate
actions in the DVC consistent with the present data indicating
POMC projections to the DVC. The low percent of POMC
neurons projecting to the DVC is in agreement with a previous
report where the authors found that the majority of POMC
neurons that project to the DVC reside in the rostral portion of the
arcuate nucleus [57]. Therefore, POMC neurons projecting to the
DVC may represent an anatomically and functionally distinct
subset of POMC neurons with sparse but important projections to
the DVC.
Heterogeneity of POMC neurons
Several reports suggest that POMC neurons in different
portions of the arcuate nucleus have distinct characteristics. For
example, (1) estradiol increases Pomc mRNA to a greater extent in
the rostral arcuate nucleus than more caudally [58]. (2)
Adrenalectomy decreases Pomc in more caudal cells [59]. And (3)
the rostral, but not caudal-most, POMC cells are activated by
leptin administration [60]. In addition to differences in the
regulation of POMC neurons, it has been proposed that the
release of co-transmitters from POMC neurons may vary across
the rostral-caudal extent of the arcuate nucleus [8]. Finally, there
is not always a 1:1 ratio of each of the POMC-derived peptides
released into terminal regions, as processing of the POMC
prohormone can vary in individual cells resulting in differential
release of peptides in specific target sites [61,62,63]. Given this
heterogeneity, it was expected that different subsets of POMC
neurons would project to select target sites. Similar to previous
studies, the results here show that POMC neurons projecting to
the DVC and PAG are more likely to reside in the rostral portion
of the arcuate nucleus ([57,64] and Figure 6). However, most
target sites appear to be innervated by POMC cells dispersed
throughout the arcuate nucleus. Nonetheless, the results to date do
not rule out the possibility that POMC neurons projecting to
individual target sites may be specialized in some way that is not
reflected by location alone such as expression of select receptors or
co-expression of specific transmitters.
Technical considerations
All tracers used for anatomic mapping of neuronal fibers have
some advantages, disadvantages and limitations [65]. The
majority of the present studies were performed using CTB as
the tracer because its utility as a retrograde tracer has been
demonstrated in numerous papers since its early use in
hypothalamic tracing studies [66]. Although anterograde labeling
can also be performed with CTB [67], without amplified
immunodetection the anterograde signal is very weak and does
not limit the ability to detect the strong label in the soma resulting
from retrograde transport [67,68]. Since there is some suggestion
that CTB may be taken up by fibers of passage, some experiments
were replicated using fluorescent microspheres which are not
taken up by fibers of passage [65]. No difference was detected in
the number of POMC cells labeled using these two tracers
suggesting CTB uptake by axon terminals selectively, although
both tracers may be taken up by damaged fibers [65]. Given the
low level of retrograde labeling observed and the consistency of the
current results with previous studies, it seems unlikely that
damaged fibers are contributing significantly to CTB labeling
seen here. Additionally, if the injection was causing significant
damage and CTB was taken up by damaged fibers, then doubling
the injection volume should increase the amount of labeling
observed which did not occur, supporting selective uptake by axon
terminals. Whereas false-positive labeling seems unlikely, it is
possible that absolute the number of cells labeled with tracer is an
underestimate since injections were made unilaterally.
Finally, the low number of labeled cells together with marked
variability between subjects limits the ability to detect small
differences between target sites or among different regions of the
arcuate nucleus. As indicated by the 95% confidence intervals only
relatively large differences in the percent of POMC cells with CTB
could be detected. Increasing the number of animals tested was
not further pursued since the total number of POMC cells with
retrograde label was consistently less than 10%. Thus even with
better statistical power, the physiologic significance of differences
in location among 10% or less of the POMC neuron population
would be difficult to interpret.
Conclusions
POMC neurons from the arcuate nucleus send projections
widely throughout the brain to affect an array of functions. The
current results suggest that only a small number of POMC
neurons terminate in any individual target site, thus relatively
sparse innervation may be sufficient to induce the physiologic
responses attributed to POMC peptide actions in specific brain
regions although contributions of brainstem POMC neurons
cannot be ruled out. Further studies will need to examine whether
the innervation of targets is plastic and if more POMC neurons
can be recruited to project to targets in a state-dependent manner.
In the absence of such plasticity, the data here suggest that
disturbed function of very few POMC neurons could have
significant consequences depending on the target site those
neurons innervate. Future studies that combine tract-tracing and
Projections from Hypothalamic POMC Neurons
PLoS ONE | www.plosone.org 8 October 2011 | Volume 6 | Issue 10 | e25864functional analyses together will provide much needed insight into
the plasticity and specificity of innervation of target sites by
POMC neurons.
Acknowledgments
The authors thank Drs. Malcolm Low and Veronica Otero-Corchon for
providing the POMC-DsRed mice.
Author Contributions
Conceived and designed the experiments: STH CMK. Performed the
experiments: CMK. Analyzed the data: STH CMK. Wrote the paper:
STH.
References
1. Coll AP (2007) Effects of pro-opiomelanocortin (POMC) on food intake and
body weight: mechanisms and therapeutic potential? Clin Sci (Lond) 113:
171–182.
2. Roth-Deri I, Green-Sadan T, Yadid G (2008) Beta-endorphin and drug-induced
reward and reinforcement. Prog Neurobiol 86: 1–21.
3. Rubinstein M, Mogil JS, Japon M, Chan EC, Allen RG, et al. (1996) Absence of
opioid stress-induced analgesia in mice lacking beta-endorphin by site-directed
mutagenesis. Proc Natl Acad Sci U S A 93: 3995–4000.
4. Maolood N, Meister B (2010) Nociceptin/orphanin FQ peptide in hypothalamic
neurones associated with the control of feeding behaviour. J Neuroendocrinol
22: 75–82.
5. Vrang N, Larsen PJ, Clausen JT, Kristensen P (1999) Neurochemical
characterization of hypothalamic cocaine- amphetamine-regulated transcript
neurons. J Neurosci 19: RC5.
6. Meister B, Gomuc B, Suarez E, Ishii Y, Durr K, et al. (2006) Hypothalamic
proopiomelanocortin (POMC) neurons have a cholinergic phenotype.
Eur J Neurosci 24: 2731–2740.
7. Hentges ST, Nishiyama M, Overstreet LS, Stenzel-Poore M, Williams JT, et al.
(2004) GABA release from proopiomelanocortin neurons. J Neurosci 24:
1578–1583.
8. Hentges ST, Otero-Corchon V, Pennock RL, King CM, Low MJ (2009)
Proopiomelanocortin expression in both GABA and glutamate neurons.
J Neurosci 29: 13684–13690.
9. Collin M, Backberg M, Ovesjo ML, Fisone G, Edwards RH, et al. (2003) Plasma
membrane and vesicular glutamate transporter mRNAs/proteins in hypotha-
lamic neurons that regulate body weight. Eur J Neurosci 18: 1265–1278.
10. Chronwall BM (1985) Anatomy and physiology of the neuroendocrine arcuate
nucleus. Peptides 6 Suppl 2: 1–11.
11. Finley JC, Lindstrom P, Petrusz P (1981) Immunocytochemical localization of
beta-endorphin-containing neurons in the rat brain. Neuroendocrinology 33:
28–42.
12. O’Donohue TL, Dorsa DM (1982) The opiomelanotropinergic neuronal and
endocrine systems. Peptides 3: 353–395.
13. O’Donohue TL, Miller RL, Jacobowitz DM (1979) Identification, character-
ization and stereotaxic mapping of intraneuronal alpha-melanocyte stimulating
hormone-like immunoreactive peptides in discrete regions of the rat brain. Brain
Res 176: 101–123.
14. Joseph SA, Pilcher WH, Bennett-Clarke C (1983) Immunocytochemical
localization of ACTH perikarya in nucleus tractus solitarius: evidence for a
second opiocortin neuronal system. Neurosci Lett 38: 221–225.
15. Palkovits M, Eskay RL (1987) Distribution and possible origin of beta-endorphin
and ACTH in discrete brainstem nuclei of rats. Neuropeptides 9: 123–137.
16. Eskay RL, Giraud P, Oliver C, Brown-Stein MJ (1979) Distribution of alpha-
melanocyte-stimulating hormone in the rat brain: evidence that alpha-MSH-
containing cells in the arcuate region send projections to extrahypothalamic
areas. Brain Res 178: 55–67.
17. Barna I, Koenig JI, Makara GB (1997) Effects of anterolateral and posterolateral
cuts around the medial hypothalamus on the immunoreactive ACTH and beta-
endorphin levels in selected brain regions of the rat. Brain Res Bull 42: 353–357.
18. Huo L, Grill HJ, Bjorbaek C (2006) Divergent regulation of proopiomelano-
cortin neurons by leptin in the nucleus of the solitary tract and in the arcuate
hypothalamic nucleus. Diabetes 55: 567–573.
19. Ellacott KL, Halatchev IG, Cone RD (2006) Characterization of leptin-
responsive neurons in the caudal brainstem. Endocrinology 147: 3190–3195.
20. Joseph SA, Michael GJ (1988) Efferent ACTH-IR opiocortin projections from
nucleus tractus solitarius: a hypothalamic deafferentation study. Peptides 9:
193–201.
21. Zheng H, Patterson LM, Rhodes CJ, Louis GW, Skibicka KP, et al. (2010) A
potential role for hypothalamomedullary POMC projections in leptin-induced
suppression of food intake. Am J Physiol Regul Integr Comp Physiol 298:
R720–728.
22. Balthasar N, Dalgaard LT, Lee CE, Yu J, Funahashi H, et al. (2005) Divergence
of melanocortin pathways in the control of food intake and energy expenditure.
Cell 123: 493–505.
23. Rossi J, Balthasar N, Olson D, Scott M, Berglund E, et al. (2011) Melanocortin-4
receptors expressed by cholinergic neurons regulate energy balance and glucose
homeostasis. Cell Metab 13: 195–204.
24. Meister B (2007) Neurotransmitters in key neurons of the hypothalamus that
regulate feeding behavior and body weight. Physiol Behav 92: 263–271.
25. Ibrahim N, Bosch MA, Smart JL, Qiu J, Rubinstein M, et al. (2003)
Hypothalamic proopiomelanocortin neurons are glucose responsive and express
K(ATP) channels. Endocrinology 144: 1331–1340.
26. Priest CA, Roberts JL (2000) Estrogen and tamoxifen differentially regulate beta-
endorphin and cFos expression and neuronal colocalization in the arcuate
nucleus of the rat. Neuroendocrinology 72: 293–305.
27. Chowen-Breed JA, Clifton DK, Steiner RA (1989) Regional specificity of
testosterone regulation of proopiomelanocortin gene expression in the arcuate
nucleus of the male rat brain. Endocrinology 124: 2875–2881.
28. Munzberg H, Huo L, Nillni EA, Hollenberg AN, Bjorbaek C (2003) Role of
signal transducer and activator of transcription 3 in regulation of hypothalamic
proopiomelanocortin gene expression by leptin. Endocrinology 144: 2121–2131.
29. Pennock RL, Hentges ST (2011) Differential expression and sensitivity of
presynaptic and postsynaptic opioid receptors regulating hypothalamic proo-
piomelanocortin neurons. J Neurosci 31: 281–288.
30. Palkovits M (1999) Interconnections between the neuroendocrine hypothalamus
and the central autonomic system. Geoffrey Harris Memorial Lecture,
Kitakyushu, Japan, October 1998. Front Neuroendocrinol 20: 270–295.
31. Cone RD (2005) Anatomy and regulation of the central melanocortin system.
Nat Neurosci 8: 571–578.
32. Kiss JZ, Cassell MD, Palkovits M (1984) Analysis of the ACTH/beta-End/
alpha-MSH-immunoreactive afferent input to the hypothalamic paraventricular
nucleus of rat. Brain Res 324: 91–99.
33. Elmquist JK (2001) Hypothalamic pathways underlying the endocrine,
autonomic, and behavioral effects of leptin. Physiol Behav 74: 703–708.
34. Douglas AJ, Bicknell RJ, Leng G, Russell JA, Meddle SL (2002) Beta-endorphin
cells in the arcuate nucleus: projections to the supraoptic nucleus and changes in
expression during pregnancy and parturition. J Neuroendocrinol 14: 768–777.
35. Ye ZY, Li DP (2011) Activation of the melanocortin-4 receptor causes enhanced
excitation in presympathetic paraventricular neurons in obese Zucker rats.
Regul Pept 166: 112–120.
36. Cowley MA, Pronchuk N, Fan W, Dinulescu DM, Colmers WF, et al. (1999)
Integration of NPY, AGRP, and melanocortin signals in the hypothalamic
paraventricular nucleus: evidence of a cellular basis for the adipostat. Neuron 24:
155–163.
37. Fekete C, Legradi G, Mihaly E, Huang QH, Tatro JB, et al. (2000) alpha-
Melanocyte-stimulating hormone is contained in nerve terminals innervating
thyrotropin-releasing hormone-synthesizing neurons in the hypothalamic
paraventricular nucleus and prevents fasting-induced suppression of prothyro-
tropin-releasing hormone gene expression. J Neurosci 20: 1550–1558.
38. Caquineau C, Leng G, Guan XM, Jiang M, Van der Ploeg L, et al. (2006)
Effects of alpha-melanocyte-stimulating hormone on magnocellular oxytocin
neurones and their activation at intromission in male rats. J Neuroendocrinol 18:
685–691.
39. Sabatier N, Caquineau C, Dayanithi G, Bull P, Douglas AJ, et al. (2003) Alpha-
melanocyte-stimulating hormone stimulates oxytocin release from the dendrites
of hypothalamic neurons while inhibiting oxytocin release from their terminals
in the neurohypophysis. J Neurosci 23: 10351–10358.
40. Elias CF, Saper CB, Maratos-Flier E, Tritos NA, Lee C, et al. (1998) Chemically
defined projections linking the mediobasal hypothalamus and the lateral
hypothalamic area. J Comp Neurol 402: 442–459.
41. Elias CF, Aschkenasi C, Lee C, Kelly J, Ahima RS, et al. (1999) Leptin
differentially regulates NPY and POMC neurons projecting to the lateral
hypothalamic area. Neuron 23: 775–786.
42. Klusa V, Svirskis S, Opmane B, Muceniece R, Skujins A, et al. (1998)
Evaluation of behavioural effects of neural melanocortin receptor antagonists
injected ICV and in VTA in rats. Neuropeptides 32: 573–580.
43. Lindblom J, Opmane B, Mutulis F, Mutule I, Petrovska R, et al. (2001) The
MC4 receptor mediates alpha-MSH induced release of nucleus accumbens
dopamine. Neuroreport 12: 2155–2158.
44. Ohgami Y, Chung E, Quock RM (2010) Nitrous oxide-induced NO-dependent
neuronal release of beta-endorphin from the rat arcuate nucleus and
periaqueductal gray. Brain Res 1366: 38–43.
45. Basbaum AI, Fields HL (1984) Endogenous pain control systems: brainstem
spinal pathways and endorphin circuitry. Annu Rev Neurosci 7: 309–338.
46. Hughes AM, Everitt BJ, Herbert J (1987) Selective effects of beta-endorphin
infused into the hypothalamus, preoptic area and bed nucleus of the stria
terminalis on the sexual and ingestive behaviour of male rats. Neuroscience 23:
1063–1073.
Projections from Hypothalamic POMC Neurons
PLoS ONE | www.plosone.org 9 October 2011 | Volume 6 | Issue 10 | e2586447. Yang J, Yang Y, Xu HT, Chen JM, Liu WY, et al. (2007) Arginine vasopressin
induces periaqueductal gray release of enkephalin and endorphin relating to
pain modulation in the rat. Regul Pept 142: 29–36.
48. Bunel DT, Delbende C, Blasquez C, Jegou S, Vaudry H (1990) Characterization
of alpha-melanocyte-stimulating hormone (alpha-MSH)-like peptides in discrete
regions of the rat brain. In vitro release of alpha-MSH from perifused
hypothalamus and amygdala. Brain Res 513: 299–307.
49. Lam MP, Gianoulakis C (2011) Effects of acute ethanol on corticotropin-
releasing hormone and beta-endorphin systems at the level of the rat central
amygdala. Psychopharmacology (Berl).
50. Boghossian S, Park M, York DA (2010) Melanocortin activity in the amygdala
controls appetite for dietary fat. Am J Physiol Regul Integr Comp Physiol 298:
R385–393.
51. Kokare DM, Dandekar MP, Singru PS, Gupta GL, Subhedar NK (2010)
Involvement of alpha-MSH in the social isolation induced anxiety- and
depression-like behaviors in rat. Neuropharmacology 58: 1009–1018.
52. Kask A, Schioth HB (2000) Tonic inhibition of food intake during inactive phase
is reversed by the injection of the melanocortin receptor antagonist into the
paraventricular nucleus of the hypothalamus and central amygdala of the rat.
Brain Res 887: 460–464.
53. Gantz I, Miwa H, Konda Y, Shimoto Y, Tashiro T, et al. (1993) Molecular
cloning, expression, and gene localization of a fourth melanocortin receptor.
J Biol Chem 268: 15174–15179.
54. Mountjoy KG, Mortrud MT, Low MJ, Simerly RB, Cone RD (1994)
Localization of the melanocortin-4 receptor (MC4-R) in neuroendocrine and
autonomic control circuits in the brain. Mol Endocrinol 8: 1298–1308.
55. Williams DL, Kaplan JM, Grill HJ (2000) The role of the dorsal vagal complex
and the vagus nerve in feeding effects of melanocortin-3/4 receptor stimulation.
Endocrinology 141: 1332–1337.
56. Li SJ, Varga K, Archer P, Hruby VJ, Sharma SD, et al. (1996) Melanocortin
antagonists define two distinct pathways of cardiovascular control by alpha- and
gamma-melanocyte-stimulating hormones. J Neurosci 16: 5182–5188.
57. Zheng H, Patterson LM, Phifer CB, Berthoud HR (2005) Brain stem
melanocortinergic modulation of meal size and identification of hypothalamic
POMC projections. Am J Physiol Regul Integr Comp Physiol 289: R247–258.
58. Cheung S, Hammer RP, Jr. (1995) Gonadal steroid hormone regulation of
proopiomelanocortin gene expression in arcuate neurons that innervate the
medial preoptic area of the rat. Neuroendocrinology 62: 283–292.
59. Pelletier G (1993) Regulation of proopiomelanocortin gene expression in rat
brain and pituitary as studied by in situ hybridization. Ann N Y Acad Sci 680:
246–259.
60. Williams KW, Margatho LO, Lee CE, Choi M, Lee S, et al. (2010) Segregation
of acute leptin and insulin effects in distinct populations of arcuate
proopiomelanocortin neurons. J Neurosci 30: 2472–2479.
61. Dennis M, Seidah NG, Chretien M (1983) Regional heterogeneity in the
processing of pro-opiomelanocortin in rat brain. Life Sci 33 Suppl 1: 49–52.
62. Kapcala LP (1986) Discordant changes between immunoreactive ACTH and
beta-endorphin in rat brain and pituitary during early development. Brain Res
364: 350–359.
63. Millington WR, Mueller GP, O’Donohue TL (1984) Regional heterogeneity in
the ratio of alpha-MSH: beta-endorphin in rat brain. Peptides 5: 841–843.
64. Yoshida M, Taniguchi Y (1988) Projection of pro-opiomelanocortin neurons
from the rat arcuate nucleus to the midbrain central gray as demonstrated by
double staining with retrograde labeling and immunohistochemistry. Arch Histol
Cytol 51: 175–183.
65. Vercelli A, Repici M, Garbossa D, Grimaldi A (2000) Recent techniques for
tracing pathways in the central nervous system of developing and adult
mammals. Brain Res Bull 51: 11–28.
66. Luppi PH, Sakai K, Salvert D, Fort P, Jouvet M (1987) Peptidergic
hypothalamic afferents to the cat nucleus raphe pallidus as revealed by a
double immunostaining technique using unconjugated cholera toxin as a
retrograde tracer. Brain Res 402: 339–345.
67. Angelucci A, Clasca F, Sur M (1996) Anterograde axonal tracing with the
subunit B of cholera toxin: a highly sensitive immunohistochemical protocol for
revealing fine axonal morphology in adult and neonatal brains. J Neurosci
Methods 65: 101–112.
68. Hahn JD, Swanson LW (2010) Distinct patterns of neuronal inputs and outputs
of the juxtaparaventricular and suprafornical regions of the lateral hypothalamic
area in the male rat. Brain Res Rev 64: 14–103.
Projections from Hypothalamic POMC Neurons
PLoS ONE | www.plosone.org 10 October 2011 | Volume 6 | Issue 10 | e25864